Close Menu

NEW YORK (GenomeWeb) – Genome-editing biotech firm EdiGene announced yesterday that it has raised $10 million in a Series pre-B Plus financing round, which was led by new investor Green Pine Capital Partners.

Series A lead investor IDG Capital and Series B lead investor Lilly Asia Ventures also participated in the pre-B Plus financing, as well as other insiders, the firm noted.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.